Hypoglycaemia in Type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 82, Issue SUPPL. 2, 2008, Pages

  Heller, Simon R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Counterregulation; Hypoglycaemia; Type 2 diabetes

Indexed keywords

ADRENALIN; GLUCAGON; INSULIN;

ADRENALIN RELEASE; ARTICLE; GLUCAGON RELEASE; HUMAN; HYPOGLYCEMIA; INSULIN RELEASE; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS;

DIABETES MELLITUS, TYPE 2; GLUCAGON; HUMANS; HYPOGLYCEMIA;

EID: 56949106794     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.09.026     Document Type: Article

References (27)

1. The Diabetes Control Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 683-689
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352 (1998) 837-853
3. Stratton I.M., Adler A.I., Neil H.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
4. Hepburn D.A., MacLeod K.M., Pell A.C., et al. Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet. Med. 10 (1993) 231-237
5. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50 (2007) 1140-1147
6. Leese G.P., Wang J., Broomhall J., et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 26 (2003) 1176-1180
7. Meneilly G.S., Cheung E., and Tuokko H. Altered responses to hypoglycaemia of healthy elderly people. J. Clin. Endocrinol. Metab. 78 (1994) 1341-1348
8. Meneilly G.S., Cheung E., and Tuokko H. Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes 43 (1994) 403-410
9. Heller S.R. Hypoglycaemia and type 2 diabetes: insulin therapy. In: Frier B.M., and Fisher B.M. (Eds). Hypoglycaemia and Diabetes. Clinical and Physiological Aspects (1992), Edward Arnold, London 393-400
10. Boden G., Soriano M., Hoeldtke R.D., and Owen O.E. Counterregulatory hormone release and glucose recovery after hypoglycemia in non-insulin-dependent diabetic patients. Diabetes 32 (1983) 1055-1059
11. Heller S.R., Macdonald I.A., and Tattersall R.B. Counterregulation in type 2 (non-insulin-dependent) diabetes mellitus. Normal endocrine and glycaemic responses, up to ten years after diagnosis. Diabetologia 30 (1987) 924-929
12. Polonsky K.S., Herold K.C., Gilden J.L., et al. Glucose counterregulation in patients after pancreatectomy-comparison with other clinical forms of diabetes. Diabetes 33 (1984) 1112-1119
13. Bolli G.B., De Feo P., Compagnucci P., et al. Abnormal glucose counterregulation in IDDM. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32 (1983) 134-141
14. Bolli G.B., Tsalikian E., Haymond M.W., et al. Defective glucose counterregulation after subcutaneous insulin in non-insulin dependent diabetes mellitus. J. Clin. Invest. 73 (1984) 1532-1541
15. Segel S.A., Paramore D.S., and Cryer P.E. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 51 (2002) 724-733
16. Unger R.H. The Berson memorial lecture. Insulin-glucagon relationships in the defense against hypoglycaemia. Diabetes 32 (1983) 575-583
17. Peacey S.R., Rostami-Hodjegan A., George E., et al. The use of tolbutamide-induced hypoglycemia to examine the intraislet role of insulin in mediating glucagon release in normal humans. J. Clin. Endocrinol. Metab. 82 (1997) 1458-1461
18. Landstedt-Hallin L., Adamson U., and Lins P.E. Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 84 (1999) 3140-3145
19. Banarer S., McGregor V.P., and Cryer P.E. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 51 (2002) 958-965
20. Heller S.R., and Cryer P.E. Hypoinsulinemia is not critical to glucose recovery from hypoglycemia in humans. Am. J. Physiol. 261 (1991) E41-E48
21. Peacey S.R., Bedford C., Marlow S., et al. Antecedent hypoglycemia does not alter the physiological response to subsequent hypoglycemia in NIDDM. Diabetes 45 (1996) 199-1199
22. Davis S.N., Mann S., Tate D., et al. Effects of antecedent hypoglycemia (AH) on counterregulatory response to subsequent hypoglycemia in patients with type 2 diabetes. Diabetes 48 (1999) 1590
23. Korzon-Burakowska A., Hopkins D., Matyka K., et al. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes. Diabetes Care 21 (1998) 283-290
24. Spyer G., Hattersley A.T., MacDonald I.A., et al. Hypoglycaemic counter-regulation at normal blood glucose concentrations in patients with well controlled type-2 diabetes. Lancet 356 (2000) 1970-1974
25. Cryer P.E. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM: a vicious cycle. Diabetes 41 (1992) 255-260
26. Peacey S.R., Robinson R., Bedford C., et al. Does the choice of treatment for type 2 diabetes affect the physiological response to hypoglycemia?. Diabetes Care 23 (2000) 1022-1023
27. Choudhary P., Mills K., Emery C., et al. Patients with type 2 diabetes treated with sulphonylureas develop symptoms of hypoglycaemia but not adrenergic or cognitive responses, at higher glucose levels than insulin treated patients. Diabetologia 48 (2005) A39-A40